Multiple Myeloma Archive - Seite 3 von 5 - IOZK

Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma

2009-10-14/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-10-14 / Biol. Blood Marrow Transplant. 2010 Mar;16(3):320-32

[Dendritic cell-based immunotherapy for multiple myeloma — review]

2009-06-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-06-01 / Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 Jun;17(3):821-5

Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma

2009-02-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-02-01 / J. Immunol. 2009 Feb;182(3):1667-73

[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]

2009-01-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-01-01 / Klin Onkol 2009;22(2):67-72

Immunotherapy of hematological malignancies using dendritic cells

2008-03-01/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2008-03-01 / Bull Cancer 2008 Mar;95(3):320-6

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides

2007-11-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-24

Current status of immunotherapy in B cell malignancies

2006-10-01/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma

2006-01-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2006-01-01 / Cytotherapy 2006;8(3):277-89

Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation

2006-01-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2006-01-01 / Leuk. Lymphoma 2006 Jan;47(1):29-37

Vaccine strategies to treat lymphoproliferative disorders

2005-12-01/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2005-12-01 / Pathology 2005 Dec;37(6):534-50